RxDoctor Payments DataLook up a doctor →

Naim Alkhouri, MD

Gastroenterology · Westlake, OHNPI 1134336662

Payments from drug & device makers

$10,130,886in general payments, 2019–2025

Across 2,196 payments — averaging $4613.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3.6M
  • Gilead$1.8M
  • Madrigal Pharmaceuticals$638K
  • GSK$398K
  • AbbVie$349K
  • Boehringer Ingelheim$315K
  • plus $3M from 54 others
$65,985in research payments, 2019–2025

Across 78 payments — averaging $845.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim International GmbH$32K
  • Pfizer$28K
  • Corcept Therapeutics$2K
  • Eli Lilly$2K
  • Gilead$1K
  • Novo Nordisk AS$121

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)66$3,649,205
Gilead262$1,812,556
Madrigal Pharmaceuticals254$637,543
GSK159$397,761
AbbVie(2 entities)142$348,960
Boehringer Ingelheim29$315,490
Genentech, Inc.38$290,989
Takeda Pharmaceuticals U.S.A., Inc.170$275,673
Perspectum Diagnostics Ltd36$270,745
Astrazeneca UK Limited2$247,672
Intercept Pharmaceuticals, Inc.131$241,899
Ipsen Biopharmaceuticals, Inc73$169,633
Novo Nordisk81$163,161
Sysmex R&d Center Americas, Inc.2$137,700
Boehringer Ingelheim International GmbH76$118,237
Novo Nordisk AS186$104,150
Pfizer22$83,490
Shionogi Inc45$80,620
Regeneron21$78,759
E.r. Squibb & Sons, L.L.C.7$75,911
Ipsen Bioscience Inc.16$73,381
Mirum Pharmaceuticals, Inc.31$71,654
Merck50$55,718
Eli Lilly4$50,498
Eisai Inc.55$48,407
Braintree Laboratories, Inc.6$44,328
Corcept Therapeutics24$42,962
Echosens North America, Inc.29$42,047
Amgen6$34,471
La Jolla Pharmaceutical Company6$32,541
Grifols Shared Services North America, Inc.15$26,653
Sonic Incytes Medical Corp.1$25,000
Siemens Medical Solutions USA, Inc.8$14,154
Exelixis Inc.14$13,957
Albireo Pharma, Inc.16$13,362
Dova Pharmaceuticals13$12,492
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC41$12,353
Theratechnologies Inc.5$8,553
W. L. Gore & Associates, Inc.4$2,393
UCB SA1$2,080
VBI Vaccine (delaware) Inc.1$1,810
Cook Medical LLC4$520
Boston Scientific4$201
Johnson & Johnson3$157
Sysmex America, Inc.1$142
Amicus Therapeutics, Inc.1$140
Lilly USA, LLC1$125
Sirtex Medical Inc1$107
Fujifilm Healthcare Americas Corporation1$100
Orphalan Inc3$80
Travere Therapeutics, Inc.16$75
Histosonics, Inc.1$59
Intra-sana Laboratories3$46
Bayer2$33
Evoke Pharma, Inc.2$31
QOL Medical, LLC1$25
Grifols USA, LLC1$22
Alnylam Pharmaceuticals Inc.1$20
Nestle Healthcare Nutrition Inc.1$19
Phathom Pharmaceuticals, Inc.1$16

How this compares

$10,130,886 in reported general payments places this provider in the 95th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio →

Medicare billing

Part B allowed, 2024
$89,297
Medicare patients
350
Services billed
918

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Westlake

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →